These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prosthetic dentistry in the treatment of movement disorders: dyskinesias and other neurological abnormalities. Sutcher H Med Hypotheses; 2001 Mar; 56(3):318-20. PubMed ID: 11359353 [TBL] [Abstract][Full Text] [Related]
5. The management of a completely edentulous patient with tardive dyskinesia. Katz W; Kaner T; Carrion J; Goldstein GR Int J Prosthodont; 2010; 23(3):217-20. PubMed ID: 20552086 [TBL] [Abstract][Full Text] [Related]
6. Tardive dyskinesia in the course of antidepressant therapy: a prevalence study and review of the literature. Yassa R; Camille Y; Belzile L J Clin Psychopharmacol; 1987 Aug; 7(4):243-6. PubMed ID: 3624506 [TBL] [Abstract][Full Text] [Related]
7. Vitamin B6 in treatment of tardive dyskinesia: a preliminary case series study. Lerner V; Kaptsan A; Miodownik C; Kotler M Clin Neuropharmacol; 1999; 22(4):241-3. PubMed ID: 10442256 [TBL] [Abstract][Full Text] [Related]
16. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients. Ulrich S; Sandmann U; Genz A Pharmacopsychiatry; 2005 Jul; 38(4):171-7. PubMed ID: 16025420 [TBL] [Abstract][Full Text] [Related]
17. The convergent and divergent validity of the Matson Evaluation of Drug Side-effects (MEDS) and the Dyskinesia Identification System: Condensed User Scale (DISCUS). Matson JL; Fodstad JC; Rivet TT J Intellect Dev Disabil; 2008 Dec; 33(4):337-44. PubMed ID: 19039694 [TBL] [Abstract][Full Text] [Related]
18. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia. Bishnoi M; Chopra K; Kulkarni SK Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1473-8. PubMed ID: 18554768 [TBL] [Abstract][Full Text] [Related]
19. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients. Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169 [TBL] [Abstract][Full Text] [Related]
20. Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia: a biochemical and neurochemical study. Bishnoi M; Chopra K; Kulkarni SK Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1130-8. PubMed ID: 17513028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]